May, 2024
May 2024
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Vivek Subbiah: His incredible leadership is providing strategic vision for Banner Health
Apr 2, 2024, 12:12

Vivek Subbiah: His incredible leadership is providing strategic vision for Banner Health

Vivek Subbiah shared a post on LinkedIn:

“So nice catching up with my great friend and colleague, the amazing Michael Kupferman in Phoenix, AZ. His insights and support at the right time made me think bigger and bolder for wider implementation of clinical trial research.

Grateful for his advice on healthcare management and administration.
His incredible leadership is providing strategic vision for Banner Health. It’s inspiring to see the impact of his work.”

Source: Vivek Subbiah/LinkedIn

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research at the MD Anderson Cancer Network and a former Associate Professor in the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center.

Dr. Vivek Subbiah has served as the principal investigator in over 100 phase I/II trials and co-investigator in over 200 clinical trials and is known for his leadership in several first-in-human and practice-changing studies that directly led to approvals from the FDA, European Medicines Agency, and other agencies across the world. He is an expert in tumor agnostic precision oncology and leads the BRAF and RET tissue agnostic studies to FDA approval.